Home haemodialysis for older patients: barriers and enablers by Dainton, M. & Dainton, M.
Canterbury Christ Church University’s repository of research outputs
http://create.canterbury.ac.uk
Please cite this publication as follows: 
Dainton, M. (2018) Home haemodialysis for older patients: barriers and enablers. 
Journal of Renal Nursing, 3 (5). pp. 286-290. ISSN 2041-1448. 
Link to official URL (if available):
https://doi.org/10.12968/jokc.2018.3.5.286
This version is made available in accordance with publishers’ policies. All material 
made available by CReaTE is protected by intellectual property law, including 
copyright law. Any use made of the contents should comply with the relevant law.
Contact: create.library@canterbury.ac.uk
 Barriers and Enablers for older people to receive home haemodialysis – A Review of the Literature 
Background 
Recent publications and reviews have sought to explain and address the relatively low numbers of 
patients requiring renal replacement therapy (RRT) who opt for home-based therapies. This is 
especially true for home haemodialysis (HHD) where despite significant advances in terms of 
available technology the numbers of patients receiving these therapies remains obstinately low. 
According to Registry data only around 17% of RRT patients were on a home based therapy in 2015. 
HHD occupies only a minority share of even that small group with only around 4% of the total 
number of RRT patients across the UK. (UKRR 2017). These figures are mirrored in many other 
developed countries. 
Sometimes the low numbers of patients receiving HHD has, at least in part been explained by the 
changing demographics of the dialysis population in most developed countries, the UK included. The 
rapid growth of dialysis programmes and ageing dialysis population together with the development 
of satellite dialysis units have been cited as reducing the need and demand for HHD. 
If the dialysis population is ageing and there is an ambition to increase the numbers of patients 
receiving HHD it is therefore necessary to consider the barriers and enablers to more, older patients 
to have access to this therapy choice. 
Prevalence 
According to the 19th Renal Registry Report (2017) there is a substantial differential between the 
median ages of those receiving HHD and those receiving peritoneal dialysis (PD) or in-centre 
haemodialysis (ICHD). According to the report, the median age for HHD patients is 55 years whereas 
the figures for PD and ICHD are 64 and 68 respectively. There is, however, considerable variation 
between units which suggests that any notion that older patients are inherently unsuitable for HHD 
would be erroneous. In one reporting area the median age for HHD patients was only 42 years, 
compared to 72 years for ICHD and 68 for PD. Five reporting areas, however, reported median ages 
for HHD that were actually higher than for PD and much closer to the figure for ICHD. 
The Renal Registry (2017) do add a caveat to the reported figures because of the relatively small 
patient numbers in many instances, but they note that significant differences arise even when 
looking at units with larger numbers of home therapy patients. The report posits that non-patient 
related factors may be impacting patient numbers using home therapies generally, and if that is the 
case there is clearly an implication that local practice may point to both barriers and enablers to 
increasing the numbers of elderly patients receiving HHD. 
The National Institute for Health and Care Excellence (NICE) (2002) recommend that all suitable 
patients should be offered a choice between HHD and ICHD. Suitable patients are described as those 
who have the ability and motivation to learn the necessary skills, are stable on treatment, relatively 
free of complicating co-morbidities, have good functioning vascular access, the availability of a carer 
and a suitable environment in which to dialyse. Whilst this guidance makes no mention of patients’ 
age, the suitability list could be seen to mitigate against older patients who might be likely to have 
more co-morbid conditions and potentially less likely to have good vascular access. However, the 
inclusion of the need to be able to learn the treatment can be overcome through the use of trained 
carers and the criteria regarding stability do not really reflect the potential benefits of frequent or 
slow nocturnal HD. The potential benefits of slower, home based, HD therapies for older people with 
multiple co-morbidities were recognised by Ross et al (2016) 
Literature Review 
Research into home therapy access for older patients (aged 65 years or more) is limited and mostly 
tends to focus on PD rather than HHD, especially since the advent of assisted PD (aPD) programmes 
that have enabled greater numbers of older and co-morbid patients to access this therapy. An 
example of this was the BOLDE study (Brown et al, 2010) which concluded that quality of life (QoL) 
of elderly patients on PD was generally superior to that of those on ICHD.  
Research into HHD, on the other hand, has generally not focussed on potential benefits to older 
patients, not least because of the small numbers generally involved. There is however, considerable 
evidence to support the benefits to patients of HHD generally, especially when patients use modified 
treatment regimens such as frequent/daily dialysis or slow nocturnal HD. A key advantage of HHD 
identified in recent years over ICHD is that patients dialysing more frequently, and avoiding the 
traditional post-weekend long interdialytic gap have significantly reduced morbidity and 
hospitalisation rates (Fotheringham et al, 2015).  
An indicator of the paucity of research in this area is that a Cochrane review into home versus in-
centre HD for elderly patients (Palmer et al, 2014) reviewed only one study of nine patients 
conducted in 2001. The review concluded that patients receiving slow HHD had improved blood 
pressure control and reduced risk of intradialytic hypotension. However, the reviewers also 
concluded that HHD patients reported more interference with social activities and greater carer 
burden than did patients receiving ICHD. Needless to say, the very small numbers in the study and 
the vintage of the reviewed research greatly limit the power of any conclusions that can be drawn 
from it. 
Weinhandl et al (2016) reviewed over 4000 HHD patient records on the United States (US) data base 
matched with a similar number of PD patients. Their data suggested that daily HHD patients 
experienced lower levels of mortality, hospitalisation and technique failure than those receiving PD. 
Other studies have demonstrated improved biochemical parameters, reduced fatigue, lower rates of 
depression and improved QoL in patients receiving frequent HHD rather than ICHD (Palmer et al, 
2014). It would seem sensible to postulate that if younger patients can derive such benefits from 
HHD then the same might also be true for older and frailer patients, possibly to a greater extent. 
Indeed a review of barriers and enablers to HHD in general (Sauve et al, 2016) identified the 
improved physical and mental well-being associated with HHD as a significant enabler to patients 
opting for this treatment modality. Closely linked to this as an enabler was the fact that HHD better 
enabled patients to maintain a normal life, in some ways contradicting Weinhandl’s 2016 findings. 
A review of the evidence by Nair (2016) included a case-study of a 76-year-old man with poor vision 
who successfully underwent training and commenced HHD using an NxStage machine. The patient 
became an ambassador for the company and travelled the country in that role, which would suggest 
that barriers to implementing HHD for older patients can be overcome. 
In terms of actual research into enablers and barriers to older patients receiving HHD the evidence is 
limited at best. In a Canadian study Harwood and Clark (2014) interviewed 13 elderly (over 65) pre-
dialysis patients and four of their healthcare professionals (HCPs) to assess the decision making 
process for ongoing treatment options. Four general themes emerged from the patient interviews, 
namely; precariousness with limited choices, personal factors, gender differences and the need for 
support. 
Staff in particular listed precariousness or frailty as a key limiting factor in terms of therapy choices. 
Patients expressed similar concerns but also mentioned the hope that their dialysis treatment would 
help them feel better and regain some lost quality of life. Personal factors discussed by the patients 
included a lack of knowledge about the dialysis process. Various educational approaches were in use 
with the patients and there was no observed superiority of one form over another. With their lack of 
information patients often made their choice based primarily on which modality best suited their 
lifestyle rather than any consideration of which might serve them best clinically. Interestingly, many 
participants were keen to avoid the hospital environment and maintain their independence as much 
as possible – which would suggest a preference for home-based therapies. An interesting aspect of 
the study was observed gender variation; the women in the study appeared far more accepting of 
their need for treatment and were much more proactive in seeking out information in preparing for 
dialysis. According to the study, the most important enabler for HHD was the availability of support 
from the renal team and resources. Patients wanted the security of knowing that there would always 
be support available whenever anything went wrong or they had a question. The question of 
resources revolved around ability to pay to travel to dialysis centres and the possible need to pay for 
private nurses to assist in the delivery of their HHD, a concern which may be less relevant under the 
NHS than the Canadian system. HCPs had an acknowledged bias for therapy selection and admitted 
to trying to steer people away from making a choice for HHD if they felt it likely to be unsuccessful. 
Harwood and Clark (2014) concluded that age alone should certainly not be a barrier to HHD but 
that in order to enable and facilitate older patients to select it as a treatment modality there is a 
need for adequate support and resourcing to be in place. Support may be informal, based upon 
family carers or organised professional support in the form of healthcare staff who could assist with 
the patients’ dialysis treatment. Patients were often unwilling to lean on family members for support 
as they feared this may become burdensome to their families. The review of barriers and enablers to 
HHD in general by Sauve et al (2016) also identified support as the most important enabler to 
patients opting for HHD and noted the issue of the burden of care, often related to increasing age 
and frailty as a significant barrier. Technical issues associated with use of the dialysis equipment and 
ability to solve minor technical problems were also seen as a barrier by many patients, something 
which newer dialysis equipment specifically tailored for home use attempts to address. 
A study into elderly patient satisfaction with both HHD and PD in New Zealand found high levels of 
patient satisfaction with both therapies and valued the independence that home therapies gave 
them. (Derrett et al, 2010). 
Lack of knowledge about treatment options was also identified as a barrier to the take-up of HHD by 
patients of all ages in a review by Koester (2013). The review also concluded that age should not be a 
barrier to HHD, noting that the oldest person who had started HHD on their programme was 88 
years-old. Morton et al (2010) in a systematic review of qualitative studies identified patient barriers 
to modality choices including; confronting mortality, fear of being a burden, decisions made by 
physicians, lack of resources and the influence of peers. Dialysis modality education is essential, and 
probably in a variety of formats, to cater for different patient learning styles. Bias from HCPs was a 
key factor mitigating against elderly patients opting for HHD, often because of assumptions about 
the degree of frailty and limitations due to co-morbidities of their patients. This sometimes meant 
education was biased towards the modalities that HCPs felt would be most appropriate for the 
patient. 
It would appear that there is a historical bias against the potential to recruit elderly patients to HHD 
programmes, perhaps based upon outdated understanding of the technological and treatment 
regimen developments in recent years. For example, Johansson and Brown (2016) in a chapter on 
choosing dialysis modalities for older patients describe an essentially binary choice between ICHD 
and PD, with no mention of HHD as a potential therapy choice for this group of patients. 
 
Discussion and Conclusions 
Many of the barriers to increased uptake of HHD by older patients are the same barriers which 
mitigate against increased use of HHD generally. These specifically relate to clinician bias about the 
degree to which patients may be able to cope with a home-based therapy. Other barriers common 
in the research, regardless of patient age, include disruption caused by the burden of care, including 
disruption to the patient’s home and family life as well as fears surrounding using the technology, 
isolation from clinical support, and vascular access. Barriers considered either harder to resolve or 
specific to older patients focus largely on frailty, complications created by co-morbidities and 
cognitive dysfunction related to the ageing process and dementia. Other identified barriers include 
lack of patient knowledge of their condition and treatment options and the possibility that older 
patients may be more resource intensive in terms of both initial training and ongoing support for 
HHD. These barriers have been summarised in figure 1 using the acronym ‘DIFFICULT’, developed 
from the themes in the literature: Disruption, Isolation, Fear, Frailty, Illness, Cognitive dysfunction, 
Unconscious bias, Learning deficit and Training availability. 
Enablers for increased use of HHD in the elderly seek to address the barriers identified above, and as 
with the barriers many are common to all patient situations regardless of age. The most important 
enabler, regardless of patient age is support, encompassing; professional support from the renal 
care team, peer support from fellow patients and that provided by patients’ families and carers. 
Shared Care or self-care models of dialysis provision are often cited as enablers to increased patient 
uptake of HHD but evidence to support the link is currently limited (Dainton, 2016). The provision of 
quality and effective patient education services, tailored to the varying needs of individual patients is 
a necessary enabler to overcome the barrier of patients who lack understanding about their 
condition and treatment options. Clearly, education for renal healthcare staff is also important in 
seeking to overcome the unconscious bias that so often mitigates against patients being considered 
for home therapies.  
Possibly among the most significant enablers in seeking to extend HHD to older patients not 
previously thought suitable are the opportunities afforded through novel treatment regimens and 
new technology. It seems especially likely that treatment regimens such as slow nocturnal or daily 
short-session HD, which have been demonstrated to improve patient outcomes and QoL in all age 
groups, would make HHD a much more viable option for older patients. Additionally, new generation 
dialysis machinery specifically designed for home use, which often utilises cartridge systems for 
machine lining, together with the availability of remote monitoring systems may make HHD more 
suitable for older patients who might be less confident in dealing with the technology or have lower 
dexterity than younger patients. A further potential enabler, and area for research, relates to the 
challenge of vascular access in older patients, referred to by both patients and healthcare staff as a 
barrier. The development of safer connection technologies that minimise trauma and infection risk 
for elderly patients with relatively poor vascular access could prove a significant enabler to more 
patients accessing HHD. The enablers have also been summarised in figure 1 using the acronym 
‘STERN’. 
In general, the greatest barrier to increasing numbers of patients engaging in HHD at all ages seems 
to remain an unconscious bias against the therapy choice, coupled with a perhaps over-cautious 
attitude to decisions on patients’ suitability. Dealing with this through education and training for 
those nurses and physicians involved in assisting patients to make dialysis modality choices may be 
the most effective way of increasing the numbers of older patients opting for HHD. Additionally, 
consideration and sharing of creative ways of facilitating HHD by patients traditionally unsuitable, in 
much the same way as has been achieved for PD patients with the adoption of aPD could also be a 
key enabler. It would be interesting to hear the experiences and strategies employed by those units 
who do already facilitate HHD by older patients in order to enable lessons to be learned and best 
practice spread. 
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 ‘STERN’ ENABLERS ‘DIFFICULT’ BARRIERS 
SUPPORT 
 Professional & technical 
 Peer support 
 Family/carer support 
DISRUPTION 
 Burden of care 
 Changes to home/Lifestyle 
 Family dynamics 
TECHNOLOGY 
 Dialysis equipment specifically designed 
for home use. 
 Remote monitoring of treatment from 
renal unit. 
 Visual communication 
ISOLATION 
 From clinical experts 
 From other patients 
FEAR 
 Of the technology 
 Vascular access/invasion of the body 
EDUCATION 
 Tailored to patient needs and age 
appropriate. 
 Use of Dialysis Modality Decision Aids 
 Staff education 
FRAILTY 
 Loss of physical ability 
ILLNESS 
 Renal symptom burden 
 Co-morbidities 
RESOURCES 
 Access to carers 
 Funding for home adaptation etc. 
 Funding for patient/carer support 
COGNITIVE DYSFUNCTION 
 Dementia 
UNCONSCIOUS BIAS 
 Of nursing/medical staff 
NOVEL TREATMENT REGIMENS 
 Short daily dialysis. 
 Nocturnal dialysis. 
 Vascular access solutions 
LEARNING DEFICIT 
 Lack of patient knowledge of condition 
and treatment options 
 Staff training deficit 
TRAINING AVAILABILITY 
 Older patients may need more input 
and/or longer time to train. 
Figure 1: STERN Enablers and DIFFICULT barriers to HHD for older patients 
 
